Skip to main content
Erschienen in: International Urology and Nephrology 2/2013

01.04.2013 | Nephrology - Original Paper

Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy

verfasst von: Ayami Ochi, Takahito Moriyama, Takashi Takei, Keiko Uchida, Kosaku Nitta

Erschienen in: International Urology and Nephrology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To the best of our knowledge, no study has compared intermittent steroid pulse therapy, according to Pozzi’s regimen, with versus without tonsillectomy.

Methods

In this retrospective cohort analysis, we compared clinical findings, histological findings according to the Oxford classification, and complete remission rates (RR), defined in terms of urinary protein excretion (U-Prot <0.3 g/g creatinine) and urinary red blood cell count (U-RBC <5/high-power field), after 1 year of treatment in patients with IgA nephropathy (IgAN), who received tonsillectomy with steroid pulse therapy (TSP group, n = 26) or steroid pulse therapy alone (SP group, n = 15).

Results

The baseline clinical and histological characteristics did not differ between the two groups. The RR for U-Prot analyzed by the Kaplan–Meier method did not differ between the groups (76.9 vs. 53.3 %). However, the RR for U-RBC was significantly higher in the TSP than in the SP group (88.4 vs. 33.3 %, log-rank test; P = 0.0008). The RRs for U-Prot and U-RBC were significantly higher in the TSP group than in the SP group (69.2 vs. 13.3 %, log-rank test; P = 0.0019). Cox’s regression analysis showed that combination therapy was associated with higher RR (odds ratio, 12.5; 95 % confidence interval, 2.91–86.7; P = 0.0002).

Conclusions

Tonsillectomy combined with steroid pulse therapy achieved higher RR after 1 year of treatment, compared with steroid pulse monotherapy in patients with IgAN. The long-term effects on renal survival should be analyzed in further studies.
Literatur
1.
Zurück zum Zitat Berger J, Hinglais N (1968) Inter capillary deposits of IgA-IgG. J Urol Nephrol (Paris) 74:694–695 Berger J, Hinglais N (1968) Inter capillary deposits of IgA-IgG. J Urol Nephrol (Paris) 74:694–695
2.
Zurück zum Zitat D’Amico G (2000) Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 36:227–237PubMedCrossRef D’Amico G (2000) Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 36:227–237PubMedCrossRef
3.
Zurück zum Zitat Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, Ponticelli C, Locatelli F (2004) Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 15:157–163PubMedCrossRef Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, Ponticelli C, Locatelli F (2004) Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 15:157–163PubMedCrossRef
4.
Zurück zum Zitat Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, Abe K, Taguma Y (2001) Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis 38:736–743PubMedCrossRef Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, Abe K, Taguma Y (2001) Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis 38:736–743PubMedCrossRef
5.
Zurück zum Zitat Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Kitamura K (2008) Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol 3:1301–1307PubMedCrossRef Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Kitamura K (2008) Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol 3:1301–1307PubMedCrossRef
6.
Zurück zum Zitat A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534–545CrossRef A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534–545CrossRef
7.
Zurück zum Zitat A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546–556CrossRef A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546–556CrossRef
8.
Zurück zum Zitat Ieiri N, Hotta O, Sato T, Taguma Y (2012) Significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy. Clin Exp Nephrol 16:122–129PubMedCrossRef Ieiri N, Hotta O, Sato T, Taguma Y (2012) Significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy. Clin Exp Nephrol 16:122–129PubMedCrossRef
9.
Zurück zum Zitat Pozzi C, Andrulli S, Pani A, Scaini P, Del Vecchio L, Fogazzi G, Vogt B, De Cristofaro V, Allegri L, Cirami L, DeniProcaccini A, Locatelli L (2010) Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy. J Am Soc Nephrol 21:1783–1790PubMedCrossRef Pozzi C, Andrulli S, Pani A, Scaini P, Del Vecchio L, Fogazzi G, Vogt B, De Cristofaro V, Allegri L, Cirami L, DeniProcaccini A, Locatelli L (2010) Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy. J Am Soc Nephrol 21:1783–1790PubMedCrossRef
10.
Zurück zum Zitat Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z (2012) Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1,155 cases in a Chinese adult population. Nephrol Dial Transplant 27:1479–1485PubMedCrossRef Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z (2012) Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1,155 cases in a Chinese adult population. Nephrol Dial Transplant 27:1479–1485PubMedCrossRef
11.
Zurück zum Zitat Li PK, Ho KK, Szeto CC, Yu LM, Lai FM (2002) Prognostic indicators of IgA nephropathy in the Chinese—clinical and pathological perspectives. Nephrol Dial Transplant 17:64–69PubMedCrossRef Li PK, Ho KK, Szeto CC, Yu LM, Lai FM (2002) Prognostic indicators of IgA nephropathy in the Chinese—clinical and pathological perspectives. Nephrol Dial Transplant 17:64–69PubMedCrossRef
12.
Zurück zum Zitat Sato M, Hotta O, Tomioka S, Horigome I, Chiba S, Miyazaki M, Noshiro H, Taguma Y (2003) Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy. Nephron Clin Pract 93:c137–c145PubMedCrossRef Sato M, Hotta O, Tomioka S, Horigome I, Chiba S, Miyazaki M, Noshiro H, Taguma Y (2003) Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy. Nephron Clin Pract 93:c137–c145PubMedCrossRef
13.
Zurück zum Zitat Szeto CC, Lai FM, To KF, Wong TY, Chow KM, Choi PC, Lui SF, Li PK (2001) The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med 110:434–437PubMedCrossRef Szeto CC, Lai FM, To KF, Wong TY, Chow KM, Choi PC, Lui SF, Li PK (2001) The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med 110:434–437PubMedCrossRef
14.
Zurück zum Zitat Shen P, He L, Li Y, Wang Y, Chan M (2007) Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients. Nephron Clin Pract 106:c157–c161PubMedCrossRef Shen P, He L, Li Y, Wang Y, Chan M (2007) Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients. Nephron Clin Pract 106:c157–c161PubMedCrossRef
15.
Zurück zum Zitat Kim BS, Kim YK, Shin YS, Kim YO, Song HC, Kim YS, Choi EJ (2009) Natural history and renal pathology in patients with isolated microscopic hematuria. Korean J Int Med 24:356–361CrossRef Kim BS, Kim YK, Shin YS, Kim YO, Song HC, Kim YS, Choi EJ (2009) Natural history and renal pathology in patients with isolated microscopic hematuria. Korean J Int Med 24:356–361CrossRef
16.
Zurück zum Zitat Manno C, Strippoli GF, D’Altri C, Torres D, Rossini M, Schena FP (2007) A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis 49:763–775PubMedCrossRef Manno C, Strippoli GF, D’Altri C, Torres D, Rossini M, Schena FP (2007) A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis 49:763–775PubMedCrossRef
17.
Zurück zum Zitat Rauta V, Finne P, Fagerudd J, Rosenlof K, Tornroth T, Gronhagen-Riska C (2002) Factors associated with progression of IgA nephropathy are related to renal function—a model for estimating risk of progression in mild disease. Clin Nephrol 58:85–94PubMed Rauta V, Finne P, Fagerudd J, Rosenlof K, Tornroth T, Gronhagen-Riska C (2002) Factors associated with progression of IgA nephropathy are related to renal function—a model for estimating risk of progression in mild disease. Clin Nephrol 58:85–94PubMed
Metadaten
Titel
Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy
verfasst von
Ayami Ochi
Takahito Moriyama
Takashi Takei
Keiko Uchida
Kosaku Nitta
Publikationsdatum
01.04.2013
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 2/2013
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-012-0251-8

Weitere Artikel der Ausgabe 2/2013

International Urology and Nephrology 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.